Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last ¥1,888 JPY
Change Today 0.00 / 0.00%
Volume 0.0
As of 1:00 AM 11/27/15 All times are local (Market data is delayed by at least 15 minutes).

r-tech ueno ltd (4573) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/9/15 - ¥2,324
52 Week Low
08/25/15 - ¥1,087
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for R-TECH UENO LTD (4573)

Related News

No related news articles were found.

r-tech ueno ltd (4573) Related Businessweek News

No Related Businessweek News Found

r-tech ueno ltd (4573) Details

R-Tech Ueno, Ltd. engages in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment of ophthalmology and dermatology worldwide. The company offers Rescula eye drops to treat glaucoma and ocular hypertension. Its product pipeline comprises UF-021, which is in Phase IIb clinical trials to treat retinitis pigmentosa; RU-101 which is in Phase IIa clinical trials for the treatment of dry eye; and RK-023 that is in Phase IIa clinical trials to treat alopecia. The company is also developing RTU-1096 for the treatment of diabetes macular edema and diabetic neuropathy; and RTU-009 for treating acute cerebral infarction and graft-versus-host diseases. In addition, it engages in contract manufacturing of injections, eye drops, liquid drugs, liquid-filled hard capsules, solid formulations, and ointments. R-Tech Ueno, Ltd. was founded in 1989 and is headquartered in Tokyo, Japan. As of October 13, 2015, R-Tech Ueno, Ltd. operates as a subsidiary of Sucampo Pharma, LLC.

80 Employees
Last Reported Date: 06/24/15
Founded in 1989

r-tech ueno ltd (4573) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

r-tech ueno ltd (4573) Key Developments

R-Tech Ueno, Ltd. Reports Earnings Results for the Second Quarter Ended September 30, 2015

R-Tech Ueno, Ltd. reported earnings results for the second quarter ended September 30, 2015. For the quarter, the company reported sales of JPY 3,887 million compared to JPY 2,728 million a year ago. Operating profit was JPY 849 million compared to JPY 411 million a year ago. Ordinary income was JPY 835 million compared to JPY 462 million a year ago. Net profit was JPY 622 million compared to JPY 356 million a year ago. Diluted net income per share was JPY 31.97 against JPY 18.36 a year ago. Net assets per share was JPY 669.52 as on September 30, 2015. Income before income taxes was JPY 827,598,000 against JPY 462,495,000 a year ago. Cash flows used in operating activities was JPY 65,189,000 against JPY 182,321,000 a year ago. Purchase of property, plant and equipment was JPY 15,255,000 against JPY 12,534,000 a year ago. Purchase of intangible assets was JPY 11,964,000 against JPY 8,668,000 a year ago.

R-Tech Ueno, Ltd. to Report Q2, 2016 Results on Nov 12, 2015

R-Tech Ueno, Ltd. announced that they will report Q2, 2016 results on Nov 12, 2015

R-Tech Ueno, Ltd., Sucampo Pharmaceuticals, Inc. - M&A Call

To discuss the launch of an all-cash tender offer in Japan by Sucampo's Japanese subsidiary and the execution of a separate share purchase agreement with certain shareholders of R-Tech Ueno to acquire all outstanding shares of R-Tech Ueno for a total consideration of JPY 33 billion


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4573:JP ¥1,888.00 JPY 0.00

4573 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4573.
View Industry Companies

Industry Analysis


Industry Average

Valuation 4573 Industry Range
Price/Earnings 21.8x
Price/Sales 4.5x
Price/Book 2.7x
Price/Cash Flow 21.5x
TEV/Sales 3.5x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact R-TECH UENO LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at